Akari Therapeutics, Plc · NASDAQ (us_market)
Healthcare · Biotechnology · United States
Akari Therapeutics, Plc, an oncology company, develops antibody-drug conjugates (ADC) for cancer-killing toxins. Its lead payload is PH1 to disrupt the function of spliceosomes and to trigger an immune response that leads to additional cancer cell killing. The company's lead product candidate is AKTX-101, a preclinical stage trop2-targeting ADC that combines PH1 with the trop2 antibody to treat solid tumor cancer types, including lung, breast, bladder, head and neck, gastric, pancreatic, colon, prostate, and others. Its payloads include PH1 is a novel payload that is a spliceosome modulator designed to disrupt RNA splicing within cancer cells. The company also develops AKTX-102, a novel bispecific ADC that utilizes PH1 as its payload to treat various solid tumor cancers. Akari Therapeutics, Plc is headquartered in Tampa, Florida.
| Event Period | Drawdown | Buy Point (Bottom) | Sell Point (Peak) | ticker.setupCols.buyScore | ticker.setupCols.sellScore | Max Return | Algo Return |
|---|---|---|---|---|---|---|---|
DROP2026-01-05$11.76 RISE2026-05-12$3.06 PEAK2026-05-28$22.05 143d | -74.0% 127d | Missed | Missed | — | — | +620.6% 16d | Missed |
DROP2025-11-28$19.44 RISE2026-04-06$3.54 PEAK2026-05-28$22.05 181d | -81.8% 129d | Missed | Missed | — | — | +522.9% 52d | Missed |
DROP2025-10-07$42.00 RISE2026-02-05$9.00 PEAK2026-02-25$10.44 141d | -78.6% 121d | Missed | Missed | — | — | +16.0% 20d | Missed |
DROP2025-09-25$44.80 RISE2025-12-23$9.80 PEAK2026-01-05$11.76 102d | -78.1% 89d | Missed | Missed | — | — | +20.0% 13d | Missed |
DROP2025-09-25$44.80 RISE2025-12-18$9.80 PEAK2026-01-05$11.76 102d | -78.1% 84d | Missed | Missed | — | — | +20.0% 18d | Missed |
DROP2025-04-24$58.40 RISE2025-09-03$26.20 PEAK2025-09-25$44.80 154d | -55.1% 132d | Missed | Missed | — | — | +71.0% 22d | Missed |
DROP2025-03-21$61.20 RISE2025-04-11$42.80 PEAK2025-04-24$58.40 34d | -30.1% 21d | Missed | Missed | — | — | +36.4% 13d | Missed |
DROP2024-11-01$111.20 RISE2025-02-28$34.80 PEAK2025-03-21$61.20 140d | -68.7% 119d | Missed | Missed | — | — | +75.9% 21d | Missed |
DROP2024-08-23$153.60 RISE2024-12-23$38.00 PEAK2025-03-21$61.20 210d | -75.3% 122d | Missed | Missed | — | — | +61.1% 88d | Missed |
DROP2024-08-23$153.60 RISE2024-12-12$38.00 PEAK2025-01-07$56.40 137d | -75.3% 111d | Missed | Missed | — | — | +48.4% 26d | Missed |
DROP2024-07-29$172.00 RISE2024-08-08$126.80 PEAK2024-08-23$153.60 25d | -26.3% 10d | Missed | Missed | — | — | +21.1% 15d | Missed |
DROP2023-12-05$133.20 RISE2024-04-11$44.00 PEAK2024-06-21$148.40 199d | -67.0% 128d | Missed | Missed | — | — | +237.3% 71d | Missed |
DROP2023-08-01$213.60 RISE2023-08-17$124.00 PEAK2023-09-28$163.20 58d | -41.9% 16d | Missed | Missed | — | — | +31.6% 42d | Missed |
DROP2023-02-09$392.00 RISE2023-06-21$124.80 PEAK2023-08-01$213.60 173d | -68.2% 132d | Missed | Missed | — | — | +71.2% 41d | Missed |
DROP2023-02-03$408.00 RISE2023-06-09$124.80 PEAK2023-08-01$213.60 179d | -69.4% 126d | Missed | Missed | — | — | +71.2% 53d | Missed |
1–15 / 25 1 / 2 | |||||||
By Karen Roman Akari Therapeutics, Plc (Nasdaq: AKTX) said President and CEO Abizer Gaslightwala was part of a Virtual Investor “What This Means” interview highlighting the company’s first abstract acceptance […]
Which stocks have an unusual volume on Thursday?
Stay up-to-date with the latest market trends in the middle of the day on Thursday. Explore the top gainers and losers during today's session in our detailed report.
European equities traded in the US as American depositary receipts were trending slightly lower late
kari Therapeutics, Plc (NASDAQ:AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel RNA splicing modulator payloads, today announced that its CEO participated in a Virtual
European equities traded in the US as American depositary receipts were tracking lower late Wednesda
The trading volume of these stocks is deviating from the norm in today's session.
Curious to know what's happening on the US markets in the middle of the day on Tuesday? Join us as we explore the top gainers and losers in today's session.
Wondering what's happening in Tuesday's pre-market session? Find an overview in this article.
US stock futures up, VNET Group shares down 3.8% after reporting Q1 loss of $(1.20) per share on $390.133 million sales. Other stocks also fall.
Discover why Akari Therapeutics PLC (NASDAQ: AKTX) stock is falling on Tuesday after last week's massive 255% rally on positive preclinical cancer data.
Gainers: PHGE +97.3%, ARTL +74.8%, QTEX +52.4%, MNTX +34.4%, HLIT +28.3%, WOK +25%, CPSH +24.7%, CODX +22.7%, MDAI +22%. Losers: AKTX -25.2%, RYOJ -18.6%, DEVS -18.6%, AKAN -17%, ADTX -16.3%, LFS -15.6%
Discover the top movers in Monday's after-hours session and stay informed about the post-market dynamics.
As the regular session of the US market on Friday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Unusual volume stocks are being observed in Friday's session.
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| AKTX | +200.37% | +74.05% | +42.13% | -69.57% |
| XLV | +2.97% | -5.72% | -3.44% | +12.69% |
| Alpha (stock − sector) | +197.40% | +79.76% | +45.57% | -82.26% |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-05-19 | -0.66 | — | +100.00% |
| 2026-03-30 | -1.80 | — | +100.00% |
| 2025-11-13 | -4.40 | -1.06 | +76.00% |
| 2025-08-13 | -4.80 | -3.92 | +18.33% |
| 2023-09-29 | -40.00 | — | +100.00% |
| 2021-06-29 | — | — | — |
| 2021-04-20 | — | -8.00 | — |
| 2020-12-11 | — | — | — |
| 2020-08-31 | — | -2.00 | — |
| 2020-05-29 | — | — | — |
| 2020-03-31 | — | — | — |
| 2019-11-04 | — | — | — |
| 2019-08-29 | -108.00 | — | +100.00% |
| 2019-05-29 | -40.00 | — | +100.00% |
| 2019-04-23 | — | — | — |
| 2018-11-15 | -8.00 | — | +100.00% |